NCT06137170 2026-03-02
RegoSeq
Bayer
Completed
Clinical Trials
15 trialsNCT05839951 2025-11-12
STAR-T
Bayer
Completed
NCT06321055 2025-05-20
An Observational Study to Learn More About Treatment With Regorafenib in People With Advanced Gastrointestinal Stromal Tumors in the United States
Bayer
Completed
NCT06029010 2025-02-26
COLONGER
Bayer
Completed
NCT05594147 2023-11-07
ROCURS
Bayer
Completed
NCT02106858 2023-07-24
StivargaPMS
Bayer
Completed
NCT03289273 2023-06-13
Observational Study to Evaluate, Under Real-world Practice Conditions, the Safety and Effectiveness of Regorafenib in Patients Diagnosed With Unresectable Hepatocellular Carcinoma (uHCC)
Bayer
Completed
NCT01933958 2022-04-01
Regorafenib Post-marketing Surveillance in Japan
Bayer
Completed
NCT03644511 2020-08-21
SORAGO-HCC
Bayer
Terminated
NCT02347852 2018-09-10
REGO-ACT
Bayer
Completed
NCT01843400 2018-08-02
Regorafenib Post-marketing Surveillance
Bayer
Completed
NCT03386825 2018-05-15
COLONG
Bayer
Completed
NCT01959269 2018-03-08
RECORA
Bayer
Completed
NCT02656524 2018-02-12
Stivarga Real Life Evidence in Hungary
Bayer
Completed
NCT02042144 2018-01-16
Correlate
Bayer
Completed